$Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study$

PremiumPress Releases

Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study

10M ago

PremiumPress Releases

Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19

10M ago

PremiumPress Releases

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

11M ago

PremiumThe Fly

Scilex announces commercial launch of ELYXYB in the U.S.

1y ago

SCLX

SRNE

PremiumThe Fly

Four new option listings and one option delisting on February 24th

1y ago

ESLT

SRNE

PremiumThe Fly

Sorrento Therapeutics approved for $75M in financing in chapter 11 case

1y ago

SCLX

SRNE

More SRNEQ News >

8STN News on the Web

2023-06-15

Sorrento Therapeutics, Inc.'s Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms and Suspends Short-Sales of Dividended Scilex Stock

Yahoo Finance

Neutral

2023-06-13

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

Yahoo Finance

Bullish

2023-05-25

3 Penny Stocks to Make You the Millionaire Next Door

InvestorPlace

Neutral

2023-05-23

Affimed N.V. (AFMD) Reports Q1 Loss, Lags Revenue Estimates

Zacks

Neutral

2023-05-15

Fulcrum Therapeutics, Inc. (FULC) Reports Q1 Loss, Misses Revenue Estimates

Zacks

Neutral

2023-05-12

Biofrontera Inc. (BFRI) Reports Q1 Loss, Misses Revenue Estimates

Zacks

Neutral

2023-05-09

Seres Therapeutics (MCRB) Reports Q1 Loss, Misses Revenue Estimates

Zacks

Neutral

2023-04-13

Bankrupt Drugmaker Sorrento’s Scilex Unit Explores Stock Sale

The Wall Street Journal

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:8STN’s Media Buzz Sentiment?

Currently, no data Available

What is DE:8STN’s weekly average amount of articles?

Currently, no data Available

What is DE:8STN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

JANXJanux Therapeutics Inc

BDXBecton Dickinson

RVTYRevvity

AVCRFAvricore Health

BGLCBioNexus Gene Lab Corp

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing